Seres Therapeutics Inc (MCRB) Insider Trading

Total insider buys:
  • $47,525,463.45
Total insider sells:
  • $53,453,169.83
Most recent insider trade:
  • Feb. 16, 2024
Most active insider trader:
  • Roger Pomerantz
Trader NameDateTitleAmountPriceTypeTotal Value
Feb. 16, 2024CFO3,939$1.08Sell$4,254.12
Feb. 16, 2024Insider3,374$1.08Sell$3,643.92
Feb. 16, 2024CEO11,549$1.08Sell$12,472.92
Oct. 30, 2023Insider2,904$1.35Sell$3,920.40
Oct. 30, 2023EVP4,156$1.35Sell$5,610.60
Oct. 30, 2023CEO8,552$1.35Sell$11,545.20
Oct. 30, 2023CFO4,066$1.35Sell$5,489.10
April 28, 2023Insider7,038$5.19Sell$36,527.22
Oct. 31, 2022Insider5,012$7.93Sell$39,745.16
July 5, 2022Major Shareholder8,738,243$3.15Buy$27,525,465.45
Nov. 22, 2019Insider3,400$3.91Sell$13,294.00
June 18, 2019Director8,888,888$2.25Buy$19,999,998.00
Jan. 28, 2019EVP5,471$5.75Sell$31,458.25
Jan. 28, 2019Insider4,378$5.75Sell$25,173.50
Dec. 17, 2018Insider14,282$6.39Sell$91,261.98
Oct. 15, 2018Insider14,279$5.94Sell$84,817.26
Sept. 17, 2018Insider42,837$7.64Sell$327,274.68
Sept. 6, 2018Insider12,518$9.10Sell$113,913.80
July 15, 2018EVP14,279$8.10Sell$115,659.90
July 10, 2018Insider32,336$9.12Sell$294,904.32
July 6, 2018CEO15,366$9.14Sell$140,445.24
June 29, 2018CEO4,496$9.10Sell$40,913.60
June 27, 2018CEO16,991$9.03Sell$153,428.73
June 25, 2018CEO26,752$9.21Sell$246,385.92
June 22, 2018CEO40,057$9.36Sell$374,933.52
June 20, 2018CEO26,492$9.33Sell$247,170.36
June 15, 2018Insider14,279$8.57Sell$122,371.03
May 9, 2018Insider233$9.00Sell$2,097.00
April 25, 2018Insider14,279$7.58Sell$108,234.82
Jan. 26, 2018Insider1,738$11.02Sell$19,152.76
Dec. 19, 2017Insider1,623$10.14Sell$16,457.22
Aug. 29, 2016Insider9,390$10.87Sell$102,069.30
July 28, 2016Insider4,156$35.18Sell$146,208.08
July 27, 2016Insider38,064$35.14Sell$1,337,568.96
July 25, 2016Insider9,390$34.18Sell$320,950.20
July 6, 2016CEO88,211$29.45Sell$2,597,813.95
July 1, 2016CEO56,789$29.81Sell$1,692,880.09
June 30, 2016CFO4,533$29.54Sell$133,904.82
June 28, 2016CFO5,001$28.28Sell$141,428.28
June 27, 2016EVP9,390$27.23Sell$255,689.70
June 2, 2016EVP8,000$31.00Sell$248,000.00
June 2, 2016CEO74,049$32.52Sell$2,408,073.48
June 1, 2016EVP16,000$29.43Sell$470,880.00
June 1, 2016CEO70,951$30.51Sell$2,164,715.01
May 25, 2016Major Shareholder1,000,000$27.60Sell$27,600,000.00
May 24, 2016CEO9,801$30.00Sell$294,030.00
May 6, 2016CEO8,507$24.31Sell$206,805.17
May 5, 2016CEO59,325$26.13Sell$1,550,162.25
May 3, 2016CEO67,367$28.70Sell$1,933,432.90
April 25, 2016EVP18,640$31.94Sell$595,361.60
First«1 of 2»Last
  • Insiders are both buying and selling Seres Therapeutics Inc stock.

  • The insider traders at Seres Therapeutics Inc are: Roger Pomerantz, John G Aunins, Eric D Shaff, David N Cook, David Arkowitz, David S Ege, Michele Trucksis, Thomas Desrosier, Noubar Afeyan, Paula Cloghessy, Health Ltp Fund Ge Nutritional, Teresa L Young, Marcus Chapman, and Ventures Fund 2007 L Flagship

  • The most active insider trader at Seres Therapeutics Inc is Roger Pomerantz with 19 trades.

  • Ventures Fund 2007 L Flagship has sold the most Seres Therapeutics Inc stock with a total value of $55,200,000.00.

  • Health Ltp Fund Ge Nutritional has bought the most Seres Therapeutics Inc stock with a total value of $55,050,930.90.

  • The most recent insider trade for Seres Therapeutics Inc was on Feb. 16, 2024.

  • The single biggest insider buy for Seres Therapeutics Inc was from Health Ltp Fund Ge Nutritional with a total value of $27,525,465.45 on July 5, 2022.

  • The single biggest insider sell for Seres Therapeutics Inc was from Ventures Fund 2007 L Flagship with a total value of $27,600,000.00 on May 25, 2016.